Literature DB >> 1543480

Study of an antiestrogenic effect of retinoic acid in MCF-7 cells.

E Demirpence1, M Pons, P Balaguer, D Gagne.   

Abstract

We recently developed the cellular model MVLN-15 in which estrogenic action can be detected by bioluminescence. Using this cellular model, we characterized the inhibitory effect of retinoic acid on the estrogen-dependent induction of luciferase transcription. We present evidence that i) the inhibitory effect of retinoic acid is not due to a simple competition between retinoic acid and estradiol for binding to the estrogen receptor, ii) a DNA sequence restricted to an estrogen-responsive element (ERE) was sufficient for the antiestrogenic effect of retinoic acid, and iii) retinoic acid does not act via a cryptic AP-1 binding site associated with this ERE. Therefore, we conclude that the antiestrogenic effect of retinoic acid is due to an inhibition of estrogen receptor activity, for example by altering the amount of estrogen receptor protein bound to the ERE or affecting the transcriptional efficiency of this complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543480     DOI: 10.1016/0006-291x(92)91614-v

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  The efficacy of 9-cis retinoic acid in experimental models of cancer.

Authors:  M M Gottardis; W W Lamph; D R Shalinsky; A Wellstein; R A Heyman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Degradation of estrogens by Rhodococcus zopfii and Rhodococcus equi isolates from activated sludge in wastewater treatment plants.

Authors:  Takeshi Yoshimoto; Fumiko Nagai; Junji Fujimoto; Koichi Watanabe; Harumi Mizukoshi; Takashi Makino; Kazumasa Kimura; Hideyuki Saino; Haruji Sawada; Hiroshi Omura
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

Review 3.  Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

Authors:  Eric Badia; Joan Oliva; Patrick Balaguer; Vincent Cavaillès
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.